Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1CNS 1

Conditions

Melanoma 10Thyroid Neoplasms 4Glioma 4Multiple Myeloma 3Thyroid Carcinoma, Anaplastic 2Lymphoma 2Hematologic Neoplasms 2Glioblastoma 2Astrocytoma 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid cancer, follicular 1Thyroid cancer, Hurthle cell 1Thyroid Cancer, Papillary 1Stomach Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Oligodendroglioma 1Neurofibromatosis 1 1Neurofibroma, Plexiform 1Neurocytoma 1Neuroblastoma 1Neoplasm Metastasis 1Melanoma, Cutaneous Malignant 1Lung Neoplasms 1Histiocytosis, Langerhans-Cell 1Ganglioneuroma 1

Interventions

AZD 6244 7trametinib 3omipalisib 1mirdametinib 1dabrafenib 1Vincristine 1Specimen Handling 1Magnetic Resonance Spectroscopy 1Lovastatin 1Dosage Forms 1Curcumin 1Control Groups 1Carboplatin 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Neurofibromatosis 1 × dabrafenib × Clear all
NCT03975829 2026-06-11

Pediatric Long-Term Follow-up and Rollover Study

Novartis

Phase 4 Active not recruiting
165 enrolled
CNSMyeloid

Astrocytoma, Ganglioneuroma, Glioblastoma, Glioma, Histiocytosis, Langerhans-Cell, Neuroblastoma, Neurofibromatosis 1, Oligodendroglioma, Ganglioglioma, Neurocytoma, Neurofibroma, Plexiform

Data powered by HemOnc (CC BY 4.0) Colophon âš¡